XML 26 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Recognition
 6 Months Ended
Dec. 31, 2021
Revenue Recognition  
Revenue Recognition

4. Revenue Recognition

Contract Balances. Contract assets primarily relate to the Company’s right to consideration in exchange for products transferred to a customer in which that right to consideration is dependent upon the customer selling these products. There was no contract asset as of December 31, 2021. As of June 30, 2021, contract assets of $21,000 was included in other current assets in the condensed consolidated balance sheet. Contract liabilities primarily relate to advances or deposits received from the Company’s customers before revenue is recognized. As of December 31, 2021 and June 30, 2021, contract liabilities of $0.2 million were included in accrued liabilities in the consolidated balance sheet.

The Company disaggregated its revenue into three product portfolios. The primary care portfolio is composed of ZolpiMist and Tuzistra. The pediatric portfolio is composed of Adzenys XR-ODT, Cotempla XR-ODT Poly-Vi-Flor, Tri-Vi-Flor, Karbinal ER and a generic Tussionex. The Consumer Health portfolio is composed of consists of over twenty consumer health products competing in large healthcare categories.

Revenues by Product Portfolio. Net revenue disaggregated by significant product portfolio for the three and six months ended December 31, 2021 and 2020 were as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

December 31, 

​

December 31, 

​

    

2021

    

2020

    

2021

    

2020

​

​

​

​

​

​

​

​

(In thousands)

Primary care portfolio

 

$

192

 

$

4,097

 

$

617

 

$

7,130

Pediatric portfolio

​

​

14,451

​

​

3,115

​

​

27,909

​

​

5,834

Consumer Health portfolio

​

​

8,482

​

​

7,935

​

​

16,496

​

​

15,703

Consolidated revenue

 

$

23,125

 

$

15,147

 

$

45,022

 

$

28,667

​

​

Revenues by Geographic location. The following table reflects the Company’s product revenues by geographic location as determined by the billing address of customers:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Three Months Ended

    

Six Months Ended

​

​

December 31, 

​

December 31, 

​

    

2021

    

2020

    

2021

    

2020

​

​

​

​

​

​

​

​

(In thousands)

U.S.

​

$

22,547

​

$

13,757

​

$

43,653

​

$

25,901

International

​

 

578

​

 

1,390

​

 

1,369

​

 

2,766

Total net revenue

​

$

23,125

​

$

15,147

​

$

45,022

​

$

28,667

​